News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
|Articles|April 11, 2012

Supreme Court Considers the Affordable Care Act

Author(s)Christopher Allen
Advertisement

.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement

Maintaining a Strong Company Culture Through Difficult Times

BySocietal CDMO
January 8th 2024
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Congress Leaves Town with Major Drug-Related Bills on Hold

ByJill Wechsler
July 28th 2023
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Large Clinical Trial Supports Alzheimer Drug Full Approval

ByJill Wechsler
July 11th 2023
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Long-Admired PEPFAR Program Caught in Abortion Debate

ByJill Wechsler
June 16th 2023
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - Artur - stock.adobe.com

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

ByJill Wechsler
June 5th 2023
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis

2

AAPS PharmSci 360 2025: Trends in Bioanalysis

3

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

4

PharmTech Weekly News Roundup – Week of November 3, 2025

5

AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us